Anthropic's Claude-led CRISPR-like discovery sparks controversy

Anthropic said its AI agent Claude led the discovery of a novel enzyme system similar to CRISPR, potentially a new gene-editing mechanism, but outside experts criticized the finding as early and incremental, not yet demonstrating gene editing. Gene-editing company stocks fell after the announcement.

• Is AI to blame for college graduates' hiring woes?2026-10-04
• US appeals court backs Pentagon's Anthropic supply-chain risk label2026-09-28
• AI companies explore rights and welfare for AI agents2026-09-27
• Anthropic says Claude leads 26% of its measured AI research work2026-09-25
• Anthropic CEO says AI could cure most diseases within a decade2026-09-24